Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
| Country | United States |
|---|---|
| Deadline | 2027-10-20 (332 days left) |
| Published | 2024-11-04 |
| Sectors | Health & life sciences, Research & innovation |
| Source | Grants.gov (US) |
Summary
Funding opportunity PAR-25-225. CFDA: 93.853
The buyer, the value, the full description and the link to the official notice are available with a free account.